尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Abbott Richard David. Director active across 2 companies, notably Co-Diagnostics, Inc.. Aggregated, 6 disclosures have been published. Activity tracked since 23 November 2024. The latest transaction was disclosed on 23 May 2026 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Abbott Richard David is President of Co-Diagnostics, Inc. (XNAS). He has 6 filings in total, and across the 6 sampled filings between 2024-11-25 and 2026-05-27, sells total 4494 EUR and buys 0 EUR, with the modal transaction nature shown as Attribution.